Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Richard Hyer
Authored Items
Is SLIT Coming Soon to the United States?
Richard Hyer
Web Exclusives
Inpatient Treatment of Asthma Is Costly
Richard Hyer
Web Exclusives
New Performance Markers of Ciclesonide Aqueous Nasal Spray for Seasonal Allergic Rhinitis
Richard Hyer
Web Exclusives
Mometasone Furoate Nasal Spray Provides Sustained Symptom Relief in Allergic Rhinitis
Richard Hyer
Web Exclusives
Significant Advances in the Treatment of Seasonal Allergies
Richard Hyer
Web Exclusives
Novel Approaches to Immunotherapy: Immunomodulation
Richard Hyer
Web Exclusives
Investigational Ciclesonide HFA Safe and Effective for Seasonal Allergic Rhinitis
Richard Hyer
Web Exclusives
Last modified: April 21, 2011